J Gen Virol Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 87 (2006), 3329-3338; DOI 10.1099/vir.0.81799-0

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oka, T.
Right arrow Articles by Takeda, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oka, T.
Right arrow Articles by Takeda, N.
Agricola
Right arrow Articles by Oka, T.
Right arrow Articles by Takeda, N.
© 2006 Society for General Microbiology

Identification of the cleavage sites of sapovirus open reading frame 1 polyprotein

Tomoichiro Oka, Mami Yamamoto, Kazuhiko Katayama, Grant S. Hansman, Satoko Ogawa, Tatsuo Miyamura and Naokazu Takeda

Department of Virology II, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashi-murayama, Tokyo 208-0011, Japan

Correspondence
Tomoichiro Oka
oka-t{at}nih.go.jp


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
 
Sapovirus (SaV), a member of the family Caliciviridae, is a causative agent of acute gastroenteritis in humans and swine and is currently divided into five genogroups, GI–GV. The proteolytic processing of the SaV open reading frame 1 (ORF1) polyprotein with a human GII SaV Mc10 strain has recently been determined and the products are arranged in the following order: NH2–p11–p28–p35 (NTPase)–p32–p14 (VPg)–p70 (Pro–Pol)–p60 (VP1)–COOH. The cleavage site between p14 (VPg) and p70 (Pro–Pol) was identified as E1055/A1056 by N-terminal amino acid sequencing. To identify other cleavage sites, a series of GII SaV Mc10 full-length clones containing disrupted potential cleavage sites in the ORF1 polyprotein were constructed and used to generate linear DNA templates for in vitro coupled transcription–translation. The translation products were analysed by SDS-PAGE or by immunoprecipitation with region-specific antibodies. N-terminal amino acid sequencing with Escherichia coli-expressed recombinant proteins was also used to identify the cleavage site between p32 and p14. These approaches enabled identification of the six cleavage sites of the Mc10 ORF1 polyprotein as E69/G70, Q325/G326, Q666/G667, E940/A941, E1055/A1056 and E1722/G1723. The alignment of the SaV full-length ORF1 amino acid sequences indicated that the dipeptides used for the cleavage sites were either E or Q at the P1 position and A, G or S at the P1' position, which were conserved in the GI, GII, GIII, GIV and GV SaV ORF1 polyprotein.

The GenBank/EMBL/DDBJ accession numbers for the nucleotide sequences reported in this paper are AY237420, AY237422, AY237423, AY646853, AY646854, AY237419, AY646855, DQ058829, AY646856, X86560, AY694184, AJ249939, AY603425, AF182760, NC_000940 and DQ125333.


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
 
The family Caliciviridae is composed of four genera, namely Sapovirus, Lagovirus, Vesivirus and Norovirus (Mayo, 2002Down). Sapovirus (SaV) is a causative agent of gastroenteritis in humans and swine (Guntapong et al., 2004Down; Guo et al., 2001aDown; Hansman et al., 2004aDown, 2006Down; Johansson et al., 2005Down; Katayama et al., 2004Down; Nakata et al., 2000Down; Noel et al., 1997Down; Robinson et al., 2002Down; Vinjé et al., 2000Down) and is currently divided into five distinct genetic groups, genogroups I (GI)–GV, on the basis of the capsid protein gene (Farkas et al., 2004Down). The SaV strains that infect pigs belong to genogroup GIII and these strains are able to multiply in cultured cells (Chang et al., 2004Down; Flynn & Saif, 1988Down); however, the strains that infect humans, which belong to genogroups GI, GII, GIV and GV, have not yet been grown in cultured cells.

The SaV genome is a linear, polyadenylated, positive-sense, single-stranded RNA of about 7.5 kb with either two or three open reading frames (ORFs) (Clarke & Lambden, 2000Down). ORF1 encodes a 250 kDa polyprotein that contains amino acid motifs characteristic of caliciviruses, including 2C-like NTPase (NTPase), VPg, 3C-like protease (Pro), 3D-like RNA-dependent RNA polymerase (Pol) and capsid protein (VP1). The functional domains in the ORF1 polyprotein were predicted on the basis of the motifs found in the picornavirus polyprotein, and these domains are highly conserved among members of the family Caliciviridae (Green et al., 2000Down; Meyers et al., 2000Down). The functions of the proteins encoded by ORF2 and ORF3 have not yet been elucidated.

Proteolytic processing of the ORF1 polyprotein is a common feature of the caliciviruses (Green et al., 2000Down) and the cleavage sites have been mapped in detail in Rabbit hemorrhagic disease virus (RHDV) (König et al., 1998Down; Martin Alonso et al., 1996Down; Meyers et al., 2000Down; Wirblich et al., 1995Down, 1996Down), Feline calicivirus (FCV) (Sosnovtsev et al., 1998Down, 2002Down; Sosnovtseva et al., 1999Down) and norovirus (NoV) (Belliot et al., 2003Down; Blakeney et al., 2003Down; Hardy et al., 2002Down; Liu et al., 1996Down, 1999Down; Seah et al., 1999Down, 2003Down; Someya et al., 2000Down). The 3C-like protease of these viruses cleaves dipeptides containing either glutamic acid (E) or glutamine (Q) at the P1 position (i.e. the amino acid immediately upstream of the scissile bond) and those containing glycine (G), alanine (A), serine (S), threonine (T), aspartic acid (D) or asparagine (N) at the P1' position (i.e. the amino acid immediately downstream of the scissile bond). We have recently identified SaV ORF1 polyprotein-cleavage products of the GII Mc10 strain and these products are arranged in the following order: NH2–p11–p28–p35 (NTPase)–p32–p14 (VPg)–p70 (Pro–Pol)–p60 (VP1)–COOH (Oka et al., 2005bDown). Site-directed mutagenesis of the GDCG motif in the 3C-like protease fully abolished the proteolytic activity of this enzyme, thus demonstrating that the viral 3C-like protease was responsible for the cleavage (Oka et al., 2005bDown).

Our recent study using an Escherichia coli expression system also revealed that GII Mc10 3C-like protease cleaves the Q/G site in the rhinovirus 3C protease-recognition sequence (Oka et al., 2005aDown) in a manner similar to that of NoV Chiba virus 3C-like protease (Someya et al., 2000Down). Although the cleavage site between p14 (VPg) and p70 (Pro–Pol) of GII Mc10 was identified as E1055/A1056 by N-terminal amino acid sequencing (Oka et al., 2005aDown), the other cleavage sites are unknown. Our cleavage-products map indicated that the GII Mc10 ORF1 polyprotein should have at least six cleavage sites between six non-structural proteins and one structural protein (Oka et al., 2005bDown).

The aim of this study was to identify the remaining five cleavage sites of the Mc10 ORF1 polyprotein. Site-directed mutagenesis, an in vitro coupled transcription–translation system and N-terminal amino acid sequencing of E. coli-expressed recombinant proteins were used to identify all of the cleavage sites. In addition, the cleavage site between p14 and p70 was confirmed by site-directed mutagenesis. The dipeptide used for the cleavage sites was conserved among 16 SaV strains and was similar to those of other members of the family Caliciviridae.


   METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
 
Virus strains and their complete nucleotide sequences.
The SaV GII Mc10, GI Mc114, GI N21 and GII Mc2 strains were isolated from infants hospitalized with acute gastroenteritis in Chiang Mai, Thailand, in 2000 (Hansman et al., 2004bDown). The GII C12 strain was isolated from an infant with gastroenteritis in Sakai, Japan, in 2001 (Katayama et al., 2004Down). The GI NongKhai-50, GI Chanthaburi-74, GV NongKhai-24 (NK24) and GII SaKaeo-15 (SK15) strains were isolated from infants with gastroenteritis in NongKhai, Chanthaburi or SaKaeo, Thailand, between November 2002 and April 2003 (Guntapong et al., 2004Down). The GIV Ehime1107 and GIV Sw278 strains were isolated from an infant with gastroenteritis in Matsuyama, Japan, in 2002, and from an adult with gastroenteritis in Solna, Sweden, in 2003 (Hansman et al., 2005dDown). RNA extraction from the stool samples, cDNA synthesis and complete genome sequencing were performed as described previously (Katayama et al., 2002Down). The SaV sequences were classified phylogenetically according to the method of Farkas et al. (2004)Down.

Full-length cDNA clones.
Plasmids containing a full-length Mc10 genome sequence with the T7 promoter, designated ‘pUC19/SaV Mc10 full-length’ and ‘pUC19/SaV Mc10 full-C1171A/ORF1’, of which the latter contains a 1169GDCG1172 to GDAG mutation in the protease, have been described previously (Oka et al., 2005bDown).

Site-directed mutagenesis.
Site-directed mutagenesis was performed by using the GeneTailor site-directed mutagenesis system (Invitrogen) with pUC19/SaV Mc10 full-length as a template. In brief, 100 ng plasmid was methylated in 16 µl reaction mixture according to the manufacturer's instructions and then PCR was performed in 100 µl reaction mixture containing 1 µl methylated DNA, 40 pmol each primer, KOD polymerase buffer, 0.2 mM each dNTP, 1 mM MgSO4 and 2 units KOD-Plus DNA polymerase (TOYOBO). The primers used for site-directed mutagenesis to generate the mutant full-length cDNA clones are represented in Table 1Down. After initial denaturation at 94 °C for 5 min, 20 cycles of amplification were performed. Each cycle consisted of denaturation at 94 °C for 30 s, primer annealing at 55 °C for 30 s and primer extension at 72 °C for 10 min, followed by a final extension at 72 °C for 15 min. E. coli DH5{alpha}-T1 cells (Invitrogen) were transformed with 2 µl PCR mixture, and the plasmids containing the mutation(s) in ORF1 were amplified. The resulting 17 full-length mutant cDNA clones were designated as follows: pUC19/SaV Mc10 full-ORF1-E69A (where E at amino acid residue 69 was changed to A), -EE6869AA (where E at amino acid position 68 was changed to A, and E at amino acid position 69 was changed to A), -Q112A, -Q325A, -E385A, -E430A, -EE429430AA, -Q666A, -EQ665666AA, -E940A, -EE939940AA, -EEE938939940AAA, -E1055A, -E10541055AA, -E1679A, -Q1690A and -E1722A. All of the full-length clones were verified by sequencing and no additional mutation was found.


View this table:
[in this window]
[in a new window]
 
Table 1. Oligonucleotides used for the site-directed mutagenesis

 
In vitro coupled transcription–translation assay and immunoprecipitation.
The template for in vitro T7 polymerase coupled transcription–translation, which consisted of linear DNA fragments containing the T7 promoter, was generated by PCR with pUC19/SaV Mc10 full-length, pUC19/SaV Mc10 full-C1171A/ORF1 and 17 full-length mutant cDNA clones. DNA fragments corresponding to the entire ORF1 [Fig. 1Down(I)] were generated with the forward primer 5'-GGATCCTAATACGACTCACTATAGGGAACAGCCACCATGgcttccaagccattctacccaatagag-3', including the T7 promoter sequence (underlined) and a start codon (bold), and antisense primer 5'-T30TTAttctaagaacctaacggcccgg, including a stop codon (bold), and designated I-Prow, -Promut, -E69A, -EE6869AA, -Q112A, -Q325A, -E385A, -E430A, -EE429430AA, -Q666A, -EQ665666AA, -E940A, -EE939940AA, -EEE938939940AAA, -E1055A, -E10541055AA, -E1679A, -Q1690A and -E1722A. The truncated ORF1 templates [Fig. 1Down(II) and (III)] were similarly generated with the forward primers 5'-GGATCCTAATACGACTCACTATAGGGAACAGCCACCATGgccaaaggaaagaccaagcatggc-3' and 5'-GGATCCTAATACGACTCACTATAGGGAACAGCCACCATGgctcccacaccaattgttac-3', including the T7 promoter-encoding sequence (underlined) and a start codon (bold), and the antisense primer described above. The products were designated II-Prow, II-Promut, -E1055A, -EE10541055AA and III-Prow, -Promut, -E1679A, -Q1690A and -E1722A.


Figure 1
View larger version (11K):
[in this window]
[in a new window]
 
Fig. 1. Diagram of the ORF1 polyprotein-cleavage map of SaV GII Mc10 and linear DNA templates containing the T7 promoter for in vitro coupled transcription–translation. The Mc10 ORF1 polyprotein-cleavage map is shown at the top. One previously identified cleavage site (E1055/A1056) and five cleavage sites identified in this study, E69/G70, Q325/G326, Q666/G667, E940/A941 and E1722/G1723, are indicated by arrows; the other five potential cleavage sites not utilized for the proteolytic processing, Q112/G113, E385/A386, E430/G431, E1679/G1680 and Q1690/A1691, are indicated by arrowheads. The E. coli-expressed proteins used to prepare region-specific antibodies are indicated as A, C and D (Oka et al., 2005bDown). The DNA templates used for the in vitro coupled transcription–translation system are shown at the bottom. The template DNA fragments were generated by PCR.

 
In vitro T7 polymerase coupled transcription–translation was performed by using a TNT T7 Quick for PCR DNA kit (Promega) according to the manufacturer's instructions. The reaction was performed in the presence of 35S-labelled methionine and cysteine (Redivue Pro-mix L-[35S] in vitro cell labeling mix; Amersham Biosciences) and 2 µl of the reaction mixture was analysed by SDS-PAGE. Immunoprecipitation was performed with 10 µl reaction mixture and 5 µg region-specific antibodies raised against E. coli-expressed recombinant proteins, A (aa 1–231), C (aa 637–812) and D (aa 941–1055), as described previously (Fig. 1Up) (Oka et al., 2005bDown). The complex was captured with protein A magnetic beads (New England Biolabs) as described previously (Oka et al., 2005bDown). The protein in the gel was blotted electrically onto a PVDF membrane (Immobilon-P; Millipore) and radiolabelled proteins were detected by a Bioimage Analyser BAS 2500 (Fujifilm).

Construction of E. coli expression plasmids.
The DNA fragment corresponding to the amino acid residues 926–1720 (nt 2789–5173) was amplified by PCR with 500 ng plasmid pUC19/SaV Mc10 full-ORF1-E1055A, which contains the nucleotide changes in the P1 position of the p14/p70 cleavage site, or UC19/SaV Mc10 full-ORF1-E1055A/C1171A, which contains an additional mutation in the GDCG motif, with a sense primer (5'-CAGGGGCCCCTGGGATCCcacaatgtttcatacctcgcc-3') including a BamHI site (underlined) and an antisense primer (5'-GCCGCTCGAGTCGACTCAGTGATGGTGATGGTGATGttcaaacactaatttggtggtctcttcactggggct-3'), including a 6xHis tag-encoding sequence (underlined), a stop codon (bold) and a SalI site (italic). The PCR products were purified and digested with BamHI and SalI (New England Biolabs) and cloned into the corresponding sites of the pGEX-4T-1 vector (Amersham Biosciences). DH5{alpha} cells (TOYOBO) were used for the transformation and propagation of the plasmids. The plasmids were designated pGEX-4T-1-{Delta}p32-p14-p70/E1055A and pGEX-4T-1-{Delta}p32-p14-p70/E1055A/C1171A. The truncated ORF1 polyproteins were expressed as fusion proteins with glutathione S-transferase (GST) at the N terminus and 6xHis tag products at the C terminus.

Expression of recombinant proteins in E. coli.
E. coli BL21-CodonPlus-RIL cells (Stratagene) were transformed with the expression plasmid and incubated at 37 °C in Luria broth in the presence of 50 µg ampicillin ml–1 and 50 µg chloramphenicol ml–1 until the OD600 value reached 0.6–0.8. Expression was induced by addition of a final concentration of 1 mM IPTG followed by incubation at 37 °C for 3 h. The E. coli lysates or purified recombinant proteins were separated by SDS-PAGE and stained with GelCode blue staining reagent (Pierce) (Oka et al., 2005aDown). The recombinant proteins were purified by using TALON resin (BD Clontech) and subjected to N-terminal amino acid sequencing (APRO Science) (Oka et al., 2005aDown).

Nucleotide and amino acid sequence analyses.
Nucleotide sequence analysis was performed with a BigDye Terminator (version 3.1) cycle sequencing ready reaction kit (Applied Biosystems) and an automated sequencer, the 3100 Avanti genetic analyser (Applied Biosystems). Nucleotide sequences were assembled with the program SEQUENCHER version 4.2.2 (Gene Codes Corporation). Nucleotide and amino acid sequences were analysed with GENETYX Mac software, version 12.2.6 (Genetyx Corporation).


   RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
 
Selection and amino acid substitution of the potential cleavage sites in the ORF1 polyprotein
Our previous study with N-terminal amino acid sequencing revealed that E1055/A1056 is the cleavage site between p14 (VPg) and p70 (Pro–Pol) in the GII Mc10 ORF1 polyprotein (Oka et al., 2005aDown). The other potential cleavage sites were selected on the basis of our findings that SaV 3C-like protease cleaves next to E or Q residues. An amino acid alignment with seven SaV strains, i.e. GI Manchester (GenBank accession no. X86560 [GenBank] ), GI Dresden (AY694184 [GenBank] ), GII Bristol (AJ249939 [GenBank] ), GII Mc10 (AY237420 [GenBank] ), GII C12 (AY603425 [GenBank] ), GIII PEC (AF182760 [GenBank] ) and GIII PEC LL14 (NC_000940 [GenBank] ), allowed us to identify six potential cleavage sites (E69/G70, Q325/G326, Q666/G667, E940/A941, E1679/G1680 and E1722/G1723) (Fig. 1Up). In addition, we tested four additional dipeptides (Q112/G113, E385/A386, E430/G431 and Q1690/A1691) (Table 1Up), because these sites were conserved among five human SaV strains: GI Manchester, GI Dresden, GII Bristol, GII Mc10 and GII C12. Although our strategy was to alter the E or Q residues at position P1 to an A residue, five of 11 potential cleavage sites, including E1055/A1056, had amino acid(s) that were able to create a potential novel cleavage site immediately upstream of the P1 position (i.e. 68EE69, 429EE430, 665EQ666, 938EEE940 and 1054EE1055) (Table 1Up). Therefore, mutant clones containing either double or triple substitutions were prepared. To this end, we constructed 17 full-length mutant cDNA clones for the 11 potential cleavage sites, as shown in Table 1Up and Fig. 1Up.

Cleavage of the ORF1 polyprotein in an in vitro coupled transcription–translation system
To identify the potential cleavage sites in the ORF1 polyprotein, 17 linear template DNAs containing the T7 promoter were amplified by PCR as described in Methods; these sites corresponded to entire ORF1 regions and were designated I-E69A, -EE6869AA, -Q112A, -Q325A, -E385A, -E430A, -EE429430AA, -Q666A, -EQ665666AA, -E940A, -EE939940AA, -EEE938939940AAA, -E1055A, -E10541055AA, -E1679A, -Q1690A and -E1722A. Then, in vitro coupled transcription–translation was performed and the expressed proteins were analysed by SDS-PAGE or immunoprecipitation. Two DNA templates, I-Prow, which encodes the wild-type protease, and I-Promut, which encodes the mutant protease, were used as the positive and negative controls for proteolytic processing. I-Prow produced at least nine proteins, i.e. p11, p14, p28, p32, p35, p46, p60, p66 and p120 (Fig. 2Down, lanes 10 and 20), whereas I-Promut produced a major 250 kDa product in SDS-PAGE (Fig. 2Down, lanes 11 and 21) (Oka et al., 2005bDown). To detect p11 and p14, immunoprecipitation with anti-A and anti-D region-specific antibodies was performed (Fig. 1Up). The detection of p70 (Pro–Pol) was difficult when the entire ORF1 region was expressed, as described previously (Oka et al., 2005bDown). A ~100 kDa product clearly visible in Fig. 2Down was present in all samples analysed, including the I-Promut sample. This suggested that it was probably an artefact of the expression system, an internal initiation product or a terminally truncated protein, and is not discussed further in this study. As shown in Fig. 2Down, 10 constructs – I-E69A, -EE6869AA, -Q325A, -Q666A, -EQ665666AA, -EE939940AA, -EEE938939940AAA, -E1055A, -E10541055AA and -E1722A – demonstrated cleavage patterns different from those of I-Prow, demonstrating clearly that the proteolytic processing of the ORF1 polyprotein was blocked in these constructs, as described in the following sections.


Figure 2
View larger version (75K):
[in this window]
[in a new window]
 
Fig. 2. Analysis of in vitro translation products. I-Prow, I-Promut and 17 I- constructs containing mutation(s) in the potential cleavage site were analysed by SDS-PAGE. p11 and p14 were detected by immunoprecipitation with anti-A and anti-D antibodies. The specific products in I-Prow and I-Promut are indicated by filled and open arrowheads, respectively. The products found in I-Prow, p120, p66, p60, p46, p35, p32, p28, p14 and p11, are indicated by dots and the newly appearing products, p180, p150, p81, p67, p39, are indicated by asterisks. Mc10 ORF1-specific proteins are indicated on the right and molecular size markers are shown on the left.

 
Cleavage site between p11 and p28
Two potential cleavage sites, E69/G70 and Q112/G113, were tested (Table 1Up; Fig. 1Up). If the cleavage site was abolished, then these two products (i.e. p11 and p28) would be expected to disappear, whereas p39, corresponding to p11–p28, would appear. In vitro coupled transcription–translation with I-E69A as the template resulted in the accumulation of p39 (Fig. 2Up, lane 1), which was immunoprecipitated with anti-A antibody (Fig. 3aDown, lane 1), indicating clearly that p39 was indeed p11–p28. The construct I-EE6869AA had a cleavage pattern identical to that of I-E69A (Fig. 2Up, lanes 1 and 2), demonstrating that the cleavage occurred between E69 and G70 and that no alternative cleavage occurred between E68 and A69. The loss of p66, which corresponds to p28–p35, was also observed in both the I-E69A and I-EE6869AA translation products (Fig. 2Up, lanes 1 and 2; Fig. 3aDown, lane 1). I-Q112A had little effect on the proteolytic processing (Fig. 2Up, lane 3), demonstrating that Q112/G113 is not a cleavage site between p11 and p28. Based on these findings, we concluded that the cleavage site between p11 and p28 is E69/G70.


Figure 3
View larger version (80K):
[in this window]
[in a new window]
 
Fig. 3. Identification of the cleavage sites of p11/p28, p28/p35 and p35/p32. (a) Immunoprecipitation of the in vitro translation products of I-E69A, I-Q325A, I-Prow and I-Promut with anti-A antibodies. The immunoprecipitated products in I-Prow and I-Promut are indicated by filled and open arrowheads, respectively. The immunoprecipitated products of I-Q325A, p66 and p11, are indicated by dots and the newly appearing product of I-E69A, p39, is indicated by an asterisk. Mc10 ORF1-specific proteins are shown on the right. (b) Immunoprecipitation of the in vitro translation products of I-Q666A, I-Prow and I-Promut with anti-C antibodies. The immunoprecipitated products in I-Prow and I-Promut are indicated by filled and open arrowheads. The newly appearing products, p150, p81 and p67, in I-Q666A are indicated by asterisks. Mc10 ORF1-specific proteins are shownon the right and newly appearing products are indicated by asterisks.

 
Cleavage site between p28 and p35
Three potential cleavage sites, Q325/G326, E385/A386 and E430/G431, were predicted between p28 and p35 (Table 1Up; Fig. 1Up). The translation products from the I-E385A, I-E430A and I-EE429430AA constructs were similar to those of I-Prow (Fig. 2Up, lanes 5, 6, 7, 10 and 20), indicating that E385/A386 and E430/G431 are not cleavage sites between p28 and p35. In contrast, the cleavage products from I-Q325A showed a loss of p28 and p35 and an accumulation of p66 (Fig. 2Up, lane 4; Fig. 3aUp, lane 2). Therefore, we concluded that the cleavage site between p28 and p35 is Q325/G326.

Cleavage site between p35 and p32
One site, Q666/G667, was tested for the putative cleavage site between p35 and p32 (Table 1Up; Fig. 1Up). The translation products from I-Q666A showed a loss of p35 and p32; in addition, a loss of p66, p46 and p120 was observed, as well as an accumulation of p67, p81 and p150 (Fig. 2Up, lane 8). The antibodies raised against fragment C immunoprecipitated p67, p81 and p150 (Fig. 3bUp, lane 1), demonstrating that these products corresponded to p35–p32, p35–p32–p14 and p35–p32–p14–p70, respectively. I-EQ665666AA had a cleavage pattern identical to that of I-Q666A (Fig. 2Up, lanes 8 and 9), indicating that alternative cleavage did not occur between E665 and A666. Based on these results, we concluded that the cleavage site between p28 and p35 is Q666/G667.

Cleavage sites between p32 and p14
E940/A941 was predicted as the putative cleavage site between p32 and p14 (Table 1Up; Fig. 1Up) (Oka et al., 2005bDown). The cleavage products from I-EE939940AA and I-EEE938939940AAA showed a loss of p32 and p14 (Fig. 2Up, lanes 13 and 14). In contrast, the translation products from I-E940A were similar to those of I-Prow (Fig. 2Up, lanes 12, 10 and 20), indicating that the newly created 939EA940 was utilized as the alternative cleavage site. These results suggested that the cleavage site between p32 and p14 was E940/A941; however, this interpretation of the results was inconclusive and, therefore, N-terminal amino acid sequencing analysis was carried out. pGEX 4T-1-{Delta}p32-p14-p70/E1055A, a plasmid encoding {Delta}p32–p14–p70 (aa 926–1720) with a mutation at 1055E/A1056 in the protease, was expressed as an N-terminal GST and C-terminal 6xHis tag fusion protein in E. coli and used to analyse the N terminus of p14, because our previous study indicated that the cleavage between p14 and p70 occurred efficiently when p14–p70 (aa 941–1720) was expressed as an N-terminal GST and C-terminal 6xHis tag fusion recombinant protein in E. coli (Oka et al., 2005aDown). Three major products of approximately 110, 84 and 26 kDa were visualized when the total lysate was analysed by SDS-PAGE (Fig. 4aDown, lane 1). These products were considered to be GST–{Delta}p32–p14–p70–6xHis, p14–p70–6xHis and GST–{Delta}p32, respectively, on the basis of their molecular sizes and their affinity to TALON resin (data not shown). N-terminal amino acid sequencing of the purified 84 kDa protein revealed the sequence AKGKT, which corresponds to aa 941–945 of the Mc10 ORF1 polyprotein. pGEX-4T-1-{Delta}p32-p14-p70/E1055A/C1171A produced a major product of 110 kDa (Fig. 4aDown, lane 2), demonstrating clearly that the proteolytic processing was dependent on the 3C-like protease, as described previously (Oka et al., 2005aDown, bDown). We therefore concluded that the cleavage site between p32 and p14 is E940/A941.


Figure 4
View larger version (32K):
[in this window]
[in a new window]
 
Fig. 4. Determination of cleavage sites of p32/p14, p14/p70 and p70/p60. (a) The {Delta}p32–p14–p70 region (aa 926–1720) with an E1055A mutation was expressed in E. coli as N-terminal GST and C-terminal 6xHis tag fusion proteins. The proteins were separated by SDS-PAGE and stained with Coomassie brilliant blue. The results for pGEX-4T-1-{Delta}p32-p14-p70/E1055A are shown in lane 1 and those for pGEX-4T-1-{Delta}p32-p14-p70/E1055A/C1171A are shown in lane 2. Mc10-specific proteins are shown on the right and molecular size markers on the left. (b) In vitro translation products of template DNA fragment (II). The products in II-Prow and II-Promut are indicated by filled and open arrowheads, respectively. The products of II-E1055A, II-EE10541055AA, p84 and p60, are indicated by dots. Mc10 ORF1-specific proteins are shown on the right. (c)In vitro translation products of template DNA fragment (III). The products in III-Prow and III-Promut are indicated by filled and open arrowheads, respectively. The products of III-E1679A and III-E1690A, p70 and p60, are indicated by dots. Mc10 ORF1-specific proteins are shown on the right.

 
Cleavage site between p14 and p70
Our previous N-terminal amino acid sequencing demonstrated that the cleavage site between p14 and p70 is E1055/A1056 (Table 1Up; Fig. 1Up) (Oka et al., 2005aDown). This conclusion was confirmed by site-directed mutagenesis. The translation products from I-E1055A and II-E1055A prevented proteolytic cleavage between p14 and p70 (Fig. 2Up, lane 15; Fig. 4bUp, lane 1). The constructs I- and II-EE10541055AA, which contain a double mutation, had a cleavage pattern identical to that of the constructs I- and II-E1055A (Fig. 2Up, lanes 16 and 17; Fig. 4bUp, lanes 1 and 2), indicating that no alternative cleavage occurred between E1054 and A1055.

Cleavage site between p70 and p60
Three potential cleavage sites, E1679/G1680, Q1690/A1691 and E1722/G1723, were predicted between p70 and p60 (Table 1Up and Fig. 1Up). The cleavage products from I-E1679A and I-Q1690A were identical to those of I-Prow (Fig. 2Up, lanes 17 and 18), indicating that E1679/G1680 and Q1690/A1691 are not cleavage sites between p70 and p60. In contrast, the cleavage products from the I-E1722A construct showed a loss of p120 and p60 and an accumulation of p180 (Fig. 2Up, lane 19). Antibodies raised against the H fragment (aa 1951–2278) (Oka et al., 2005bDown) immunoprecipitated p180 from the I-E1722A construct (data not shown), demonstrating that p180 corresponds to p120–p60. To further confirm the cleavage between E1722 and G1723, III-Prow was expressed (Fig. 1Up). We observed two proteins, p70 and p60, as described previously (Fig. 4cUp, lane 4) (Oka et al., 2005bDown). In contrast, III-Promut produced a single major band, p130 (Fig. 4cUp, lane 5). III-E1722A produced a p130 band, as did III-Promut (Fig. 4cUp, lanes 3 and 5). In contrast, the cleavage patterns from III-E1679A and III-Q1690A were identical to those of III-Prow (Fig. 4cUp, lanes 1, 2 and 4). Therefore, we concluded that the cleavage site between p70 and p60 is E1722/G1723.

Cleavage sites of the ORF1 polyprotein
The cleavage sites of the SaV GII Mc10 ORF1 polyprotein were identified as E69/G70, Q325/G326, Q666/G667, E940/A941, E1055/A1056 and E1722/G1723 (Table 2Down). Although seven full-length SaV genome sequences, including Mc10, were available at the beginning of this study, we had recently determined nine human full-length SaV genome sequences: the GI Mc114, N21, Nongkhai50, Chantaburi74, GIIMc2, SK15, GIVEhime1107, Sw278 and GV NK24 strains. The cleavage sites in ORF1 were highly conserved among these 16 SaV strains and either E or Q was found at the P1 position, whereas A, G or S was found at the P1' position (Table 3Down). The dipeptide sequences at the cleavage sites were similar to those of other caliciviruses, namely, E or Q at the P1 position and A, G, S, T, D or N at the P1' position (Table 2Down).


View this table:
[in this window]
[in a new window]
 
Table 2. Comparison of viral polyprotein-cleavage sites

The amino acid sequences between P4 and P4' for RHDV, FCV and NoVs are from Wirblich et al. (1995Down, 1996)Down, Sosnovtsev et al. (2002)Down, Liu et al. (1996Down, 1999)Down and Belliot et al. (2003)Down. The cleavage sites of the Mc10 strain are in italic.

 

View this table:
[in this window]
[in a new window]
 
Table 3. Alignment of the amino acid sequences surrounding cleavage sites of 16 SaV strains

The amino acid sequences surrounding the cleavage sites of the Mc10 strain are in italic. Amino acids shown in bold represent the P1 and P1' positions of the cleavage sites.

 

   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
 
The cleavage sites of SaV ORF1 polyprotein were identified completely by using the GII Mc10 strain, which confirmed our previous predictions (Oka et al., 2005aDown). Multiple alignment of 16 SaV ORF1 amino acid sequences revealed that the amino acids for the cleavage sites (P1/P1') are either E or Q at the P1 position and G, A or S at the P1' position (Table 3Up), which have also been observed in other members of the family Caliciviridae, i.e. RHDV, FCV and NoV (Table 2Up) (Belliot et al., 2003Down; Liu et al., 1996Down, 1999Down; Sosnovtsev et al., 2002Down; Wirblich et al., 1995Down, 1996Down). Site-directed mutagenesis demonstrated clearly that the P1 amino acid plays a critical role in SaV Mc10 ORF1 proteolytic processing, as observed similarly in RHDV (Martin Alonso et al., 1996Down; Meyers et al., 2000Down; Wirblich et al., 1995Down), FCV (Sosnovtsev et al., 1998Down, 2002Down) and NoV (Belliot et al., 2003Down; Blakeney et al., 2003Down; Hardy et al., 2002Down; Liu et al., 1996Down; Seah et al., 1999Down, 2003Down). In addition, our studies also revealed that additional factors are important for the recognition of the cleavage site by an SaV 3C-like protease, because (i) although the dipeptide sequences corresponding to 1679EG1680 in the Mc10 sequence were conserved among the 16 strains, they were never utilized as a cleavage site, and (ii) the newly generated dipeptide sequences, 68EA69, 665EA666, 938EA939 and 1054EA1055, which are positioned immediately upstream of the identified cleavage sites, were not recognized as alternative cleavage sites, with the exception of 939EA940. The role of the amino acid sequence surrounding cleavage sites has been reported in other caliciviruses (Belliot et al., 2003Down; Hardy et al., 2002Down; Wirblich et al., 1995Down). Hardy et al. (2002)Down noted the importance of phenylalanine (F) at the P4 position to achieve efficient cleavage between p48 (N-terminal protein) and p41 (NTPase) of the NoV Norwalk virus. Interestingly, Y and F were found at the P4 position in NoVs MD145 (p37/p40) and Southampton viruses (p45/p40), respectively (Table 2Up). Similarly, an F residue was found at the P4 position in three of five cleavage sites in the ORF1 and one in the ORF2 of FCV (Table 2Up). In contrast, the amino acid at the P4 position of the RHDV ORF1 polyprotein was not conserved (Table 2Up). As shown in Tables 2 and 3UpUp, either F or Y is found at P4 in five of six cleavage sites in the Mc10 ORF1. In a future study, it would be interesting to evaluate whether these amino acids play crucial roles in proteolytic processing, because these P4 amino acids (F or Y) were completely conserved (except for the p32/p14 cleavage site) among the 16 SaV strains (data not shown).

In addition, it appears that proteolytic processing is regulated by other factors, because (i) the construct E1722A (Fig. 2Up, lane 19), which contains mutations far from the original cleavage sites, Q666/G667 and E1055/A1056, led to a decreased production of p46, and (ii) the mutant constructs E430A and E429430AA seem to have decreased the proteolytic activity between p28 and p35 and were likely to have caused the accumulation of p66 (Fig. 2Up, lanes 6 and 7). The mutations E430A and E429430AA were positioned in the helix domain of p35 (NTPase) (data not shown). Paul et al. (1994)Down also reported that the proteolytic processing of the poliovirus polyprotein was affected when an amino acid substitution was introduced in the 2C NTPase N-terminal helix region. Sosnovtsev et al. (1998Down, 2002)Down demonstrated in the mutagenesis of an FCV infectious cDNA clone that the proteolytic processing of the virus-encoded polyprotein is critical for the growth of the virus. The ORF1 polyprotein of SaV and RHDV encodes both the non-structural proteins and the major structural protein (VP1), and Parra et al. (1993)Down reported that the purified RHDV virion had only an MEG sequence in its N terminus and suggested that the RHDV virion was derived from subgenomic RNA. In contrast, Sibilia et al. (1995)Down reported that both RHDV VP1 translated from the subgenomic RNA and that cleaved from ORF1 polyprotein led to the assembly of virus-like particles (VLPs) that were antigenically similar to purified viruses. Although the N terminus of the VP1 of the native SaV virion has not yet been determined, the expression of the putative VP1 with either MEG or MEA at its N terminus has been shown to form VLPs in SaV GI, GII, GIII and GV strains in insect or mammalian cells (Chen et al., 2004Down; Guo et al., 2001bDown; Hansman et al., 2005aDown, bDown, cDown; Jiang et al., 1999Down; Numata et al., 1997Down; Oka et al., 2006Down). Because the cleavage site, E1722/G1723, is in the proximity of the putative capsid start codon of the subgenomic RNA, it is of interest to determine whether the VP1 produced from the SaV ORF1 polyprotein would be able to form VLPs.

In conclusion, we defined the cleavage sites of the ORF1 polyprotein of the SaV GII Mc10 strain by expressing mutant constructs in an in vitro coupled transcription–translation system and by N-terminal amino acid sequencing of the E. coli-expressed recombinant proteins. Our study demonstrated that the cleavage sites were highly conserved among genetically and antigenically different SaV strains, and therefore have important role(s) in SaV replication.


   ACKNOWLEDGEMENTS
 
This work was supported in part by a grant for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labor and Welfare of Japan, and by a grant from The Japan Health Science Foundation for Research on Health Sciences Focusing on Drug Innovation.


   REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
 
Belliot, G., Sosnovtsev, S. V., Mitra, T., Hammer, C., Garfield, M. & Green, K. Y. (2003). In vitro proteolytic processing of the MD145 norovirus ORF1 nonstructural polyprotein yields stable precursors and products similar to those detected in calicivirus-infected cells. J Virol 77, 10957–10974.[Abstract/Free Full Text]

Blakeney, S. J., Cahill, A. & Reilly, P. A. (2003). Processing of Norwalk virus nonstructural proteins by a 3C-like cysteine proteinase. Virology 308, 216–224.[CrossRef][Medline]

Chang, K.-O., Sosnovtsev, S. V., Belliot, G., Kim, Y., Saif, L. J. & Green, K. Y. (2004). Bile acids are essential for porcine enteric calicivirus replication in association with down-regulation of signal transducer and activator of transcription 1. Proc Natl Acad Sci U S A 101, 8733–8738.[Abstract/Free Full Text]

Chen, R., Neill, J. D., Noel, J. S., Hutson, A. M., Glass, R. I., Estes, M. K. & Prasad, B. V. V. (2004). Inter- and intragenus structural variations in caliciviruses and their functional implications. J Virol 78, 6469–6479.[Abstract/Free Full Text]

Clarke, I. N. & Lambden, P. R. (2000). Organization and expression of calicivirus genes. J Infect Dis 181 (Suppl. 2), S309–S316.

Farkas, T., Zhong, W. M., Jing, Y. & 7 other authors (2004). Genetic diversity among sapoviruses. Arch Virol 149, 1309–1323.[Medline]

Flynn, W. T. & Saif, L. J. (1988). Serial propagation of porcine enteric calicivirus-like virus in primary porcine kidney cell cultures. J Clin Microbiol 26, 206–212.[Abstract/Free Full Text]

Green, K. Y., Ando, T., Balayan, M. S. & 8 other authors (2000). Taxonomy of the caliciviruses. J Infect Dis 181 (Suppl. 2), S322–S330.

Guntapong, R., Hansman, G. S., Oka, T., Ogawa, S., Kageyama, T., Pongsuwanna, Y. & Katayama, K. (2004). Norovirus and sapovirus infections in Thailand. Jpn J Infect Dis 57, 276–278.[Medline]

Guo, M., Hayes, J., Cho, K. O., Parwani, A. V., Lucas, L. M. & Saif, L. J. (2001a). Comparative pathogenesis of tissue culture-adapted and wild-type Cowden porcine enteric calicivirus (PEC) in gnotobiotic pigs and induction of diarrhea by intravenous inoculation of wild-type PEC. J Virol 75, 9239–9251.[Abstract/Free Full Text]

Guo, M., Qian, Y., Chang, K.-O. & Saif, L. J. (2001b). Expression and self-assembly in baculovirus of porcine enteric calicivirus capsids into virus-like particles and their use in an enzyme-linked immunosorbent assay for antibody detection in swine. J Clin Microbiol 39, 1487–1493.[Abstract/Free Full Text]

Hansman, G. S., Doan, L. T., Kguyen, T. A. & 9 other authors (2004a). Detection of norovirus and sapovirus infection among children with gastroenteritis in Ho Chi Minh City, Vietnam. Arch Virol 149, 1673–1688.[Medline]

Hansman, G. S., Katayama, K., Maneekarn, N. & 7 other authors (2004b). Genetic diversity of norovirus and sapovirus in hospitalized infants with sporadic cases of acute gastroenteritis in Chiang Mai, Thailand. J Clin Microbiol 42, 1305–1307.[Abstract/Free Full Text]

Hansman, G. S., Katayama, K., Oka, T., Natori, K. & Takeda, N. (2005a). Mutational study of sapovirus expression in insect cells. Virol J 2, 13.[CrossRef][Medline]

Hansman, G. S., Matsubara, N., Oka, T., Ogawa, S., Natori, K., Takeda, N. & Katayama, K. (2005b). Deletion analysis of the sapovirus VP1 gene for the assembly of virus-like particles. Arch Virol 150, 2529–2538.[CrossRef][Medline]

Hansman, G. S., Natori, K., Oka, T., Ogawa, S., Tanaka, K., Nagata, N., Ushijima, H., Takeda, N. & Katayama, K. (2005c). Cross-reactivity among sapovirus recombinant capsid proteins. Arch Virol 150, 21–36.[CrossRef][Medline]

Hansman, G. S., Takeda, N., Oka, T., Oseto, M., Hedlund, K. O. & Katayama, K. (2005d). Intergenogroup recombination in sapoviruses. Emerg Infect Dis 11, 1916–1920.[Medline]

Hansman, G. S., Takeda, N., Katayama, K., Tu, E. T., McIver, C. J., Rawlinson, W. D. & White, P. A. (2006). Genetic diversity of Sapovirus in children, Australia. Emerg Infect Dis 12, 141–143.[Medline]

Hardy, M. E., Crone, T. J., Brower, J. E. & Ettayebi, K. (2002). Substrate specificity of the Norwalk virus 3C-like proteinase. Virus Res 89, 29–39.[CrossRef][Medline]

Jiang, X., Zhong, W., Kaplan, M., Pickering, L. K. & Matson, D. O. (1999). Expression and characterization of Sapporo-like human calicivirus capsid proteins in baculovirus. J Virol Methods 78, 81–91.[CrossRef][Medline]

Johansson, P. J. H., Bergentoft, K., Larsson, P. A., Magnusson, G., Widell, A., Thorhagen, M. & Hedlund, K.-O. (2005). A nosocomial sapovirus-associated outbreak of gastroenteritis in adults. Scand J Infect Dis 37, 200–204.[CrossRef][Medline]

Katayama, K., Shirato-Horikoshi, H., Kojima, S. & 9 other authors (2002). Phylogenetic analysis of the complete genome of 18 Norwalk-like viruses. Virology 299, 225–239.[CrossRef][Medline]

Katayama, K., Miyoshi, T., Uchino, K., Oka, T., Tanaka, T., Takeda, N. & Hansman, G. S. (2004). Novel recombinant sapovirus. Emerg Infect Dis 10, 1874–1876.[Medline]

König, M., Thiel, H.-J. & Meyers, G. (1998). Detection of viral proteins after infection of cultured hepatocytes with rabbit hemorrhagic disease virus. J Virol 72, 4492–4497.[Abstract/Free Full Text]

Liu, B., Clarke, I. N. & Lambden, P. R. (1996). Polyprotein processing in Southampton virus: identification of 3C-like protease cleavage sites by in vitro mutagenesis. J Virol 70, 2605–2610.[Abstract]

Liu, B. L., Viljoen, G. J., Clarke, I. N. & Lambden, P. R. (1999). Identification of further proteolytic cleavage sites in the Southampton calicivirus polyprotein by expression of the viral protease in E. coli. J Gen Virol 80, 291–296.[Abstract]

Martin Alonso, J. M., Casais, R., Boga, J. A. & Parra, F. (1996). Processing of rabbit hemorrhagic disease virus polyprotein. J Virol 70, 1261–1265.[Abstract]

Mayo, M. A. (2002). A summary of taxonomic changes recently approved by ICTV. Arch Virol 147, 1655–1663.[CrossRef][Medline]

Meyers, G., Wirblich, C., Thiel, H.-J. & Thumfart, J. O. (2000). Rabbit hemorrhagic disease virus: genome organization and polyprotein processing of a calicivirus studied after transient expression of cDNA constructs. Virology 276, 349–363.[CrossRef][Medline]

Nakata, S., Honma, S., Numata, K. K., Kogawa, K., Ukae, S., Morita, Y., Adachi, N. & Chiba, S. (2000). Members of the family Caliciviridae (Norwalk virus and Sapporo virus) are the most prevalent cause of gastroenteritis outbreaks among infants in Japan. J Infect Dis 181, 2029–2032.[CrossRef][Medline]

Noel, J. S., Liu, B. L., Humphrey, C. D. & 7 other authors (1997). Parkville virus: a novel genetic variant of human calicivirus in the Sapporo virus clade, associated with an outbreak of gastroenteritis in adults. J Med Virol 52, 173–178.[CrossRef][Medline]

Numata, K., Hardy, M. E., Nakata, S., Chiba, S. & Estes, M. K. (1997). Molecular characterization of morphologically typical human calicivirus Sapporo. Arch Virol 142, 1537–1552.[CrossRef][Medline]

Oka, T., Katayama, K., Ogawa, S., Hansman, G. S., Kageyama, T., Miyamura, T. & Takeda, N. (2005a). Cleavage activity of the sapovirus 3C-like protease in Escherichia coli. Arch Virol 150, 2539–2548.[CrossRef][Medline]

Oka, T., Katayama, K., Ogawa, S., Hansman, G. S., Kageyama, T., Ushijima, H., Miyamura, T. & Takeda, N. (2005b). Proteolytic processing of sapovirus ORF1 polyprotein. J Virol 79, 7283–7290.[Abstract/Free Full Text]

Oka, T., Hansman, G. S., Katayama, K., Ogawa, S., Nagata, N., Miyamura, T. & Takeda, N. (2006). Expression of sapovirus virus-like particles in mammalian cells. Arch Virol 151, 399–404.[CrossRef][Medline]

Parra, F., Boga, J. A., Marin, M. S. & Casais, R. (1993). The amino terminal sequence of VP60 from rabbit hemorrhagic disease virus supports its putative subgenomic origin. Virus Res 27, 219–228.[CrossRef][Medline]

Paul, A. V., Molla, A. & Wimmer, E. (1994). Studies of a putative amphipathic helix in the N-terminus of poliovirus protein 2C. Virology 199, 188–199.[CrossRef][Medline]

Robinson, S., Clarke, I. N., Vipond, I. B., Caul, E. O. & Lambden, P. R. (2002). Epidemiology of human Sapporo-like caliciviruses in the South West of England: molecular characterisation of a genetically distinct isolate. J Med Virol 67, 282–288.[CrossRef][Medline]

Seah, E. L., Marshall, J. A. & Wright, P. J. (1999). Open reading frame 1 of the Norwalk-like virus Camberwell: completion of sequence and expression in mammalian cells. J Virol 73, 10531–10535.[Abstract/Free Full Text]

Seah, E. L., Marshall, J. A. & Wright, P. J. (2003). trans Activity of the norovirus Camberwell proteinase and cleavage of the N-terminal protein encoded by ORF1. J Virol 77, 7150–7155.[Abstract/Free Full Text]

Sibilia, M., Boniotti, M. B., Angoscini, P., Capucci, L. & Rossi, C. (1995). Two independent pathways of expression lead to self-assembly of the rabbit hemorrhagic disease virus capsid protein. J Virol 69, 5812–5815.[Abstract]

Someya, Y., Takeda, N. & Miyamura, T. (2000). Complete nucleotide sequence of the Chiba virus genome and functional expression of the 3C-like protease in Escherichia coli. Virology 278, 490–500.[CrossRef][Medline]

Sosnovtsev, S. V., Sosnovtseva, S. A. & Green, K. Y. (1998). Cleavage of the feline calicivirus capsid precursor is mediated by a virus-encoded proteinase. J Virol 72, 3051–3059.[Abstract/Free Full Text]

Sosnovtsev, S. V., Garfield, M. & Green, K. Y. (2002). Processing map and essential cleavage sites of the nonstructural polyprotein encoded by ORF1 of the feline calicivirus genome. J Virol 76, 7060–7072.[Abstract/Free Full Text]

Sosnovtseva, S. A., Sosnovtsev, S. V. & Green, K. Y. (1999). Mapping of the feline calicivirus proteinase responsible for autocatalytic processing of the nonstructural polyprotein and identification of a stable proteinase-polymerase precursor protein. J Virol 73, 6626–6633.[Abstract/Free Full Text]

Vinjé, J., Deijl, H., van der Heide, R., Lewis, D., Hedlund, K. O., Svensson, L. & Koopmans, M. P. (2000). Molecular detection and epidemiology of Sapporo-like viruses. J Clin Microbiol 38, 530–536.[Abstract/Free Full Text]

Wirblich, C., Sibilia, M., Boniotti, M. B., Rossi, C., Thiel, H. J. & Meyers, G. (1995). 3C-like protease of rabbit hemorrhagic disease virus: identification of cleavage sites in the ORF1 polyprotein and analysis of cleavage specificity. J Virol 69, 7159–7168.[Abstract]

Wirblich, C., Thiel, H. J. & Meyers, G. (1996). Genetic map of the calicivirus rabbit hemorrhagic disease virus as deduced from in vitro translation studies. J Virol 70, 7974–7983.[Abstract]

Received 28 December 2005; accepted 26 June 2006.


This article has been cited by other articles:


Home page
J. Virol.Home page
I. Robel, J. Gebhardt, J. R. Mesters, A. Gorbalenya, B. Coutard, B. Canard, R. Hilgenfeld, and J. Rohayem
Functional Characterization of the Cleavage Specificity of the Sapovirus Chymotrypsin-Like Protease
J. Virol., August 15, 2008; 82(16): 8085 - 8093.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Oka, M. Yamamoto, M. Yokoyama, S. Ogawa, G. S. Hansman, K. Katayama, K. Miyashita, H. Takagi, Y. Tohya, H. Sato, et al.
Highly Conserved Configuration of Catalytic Amino Acid Residues among Calicivirus-Encoded Proteases
J. Virol., July 1, 2007; 81(13): 6798 - 6806.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oka, T.
Right arrow Articles by Takeda, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oka, T.
Right arrow Articles by Takeda, N.
Agricola
Right arrow Articles by Oka, T.
Right arrow Articles by Takeda, N.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS